CVS Health (CVS) JP Morgan 37th Annual Healthcare conference summary
Event summary combining transcript, slides, and related documents.
JP Morgan 37th Annual Healthcare conference summary
4 Nov, 2026Operating platform and Aetna transaction
Retail includes >9,800 pharmacies, 25% retail prescription share and >1,100 MinuteClinics; Caremark serves 93M members and specialty pharmacy dispenses >$35B annually.
Aetna acquisition closed Nov. 28, 2018, at ~$70B equity value and ~$78B total value including assumed debt; funding included $40B senior notes, $5B borrowings and 274.4M shares.
Integration continued during district court and Tunney Act review; review was not expected to affect the synergy timeline. Debt was ~$76B excluding leases.
Consumer health strategy and savings
Priorities: local access, simpler care navigation and improved health through community, home and digital touchpoints; existing engagement reaches one in three Americans.
The system was characterized as complex, episodic and fragmented; a consumer-focused front door would address chronic disease, readmissions, site of care, primary care and complex chronic care.
U.S. medical spending was cited at $2.4T, including $2.1T or 86% associated with chronic disease; $500B was estimated as preventable, with $25B-$100B in potential savings.
Medical-cost levers include chronic-condition management, fewer readmissions, lower-cost care sites, reduced unnecessary ER visits and expanded primary care.
Each 50 bps reduction in medical-cost trend was linked to ~$500M of additional underwriting margin; savings could support competitive investment and membership growth.
Integration milestones and health programs
Targeting >$750M in 2020 or year-two synergies from integration, G&A, vendor contracting and medical-cost savings; redundant-function benefits expected from Q1 2019.
Purchasing, formulary and plan-design benefits expected through H1 2019, with medical-cost savings toward year-end; 2019-2020 work included corporate rationalization and procurement alignment.
High-risk member adherence outreach launched in Q4 2018; cardiovascular services, post-discharge MinuteClinic follow-up and care-management pilots were planned for Q1 2019.
Houston concept store planned for February 2019, testing concierge services, chronic-disease screening, in-clinic phlebotomy and prescription support; concept stores also feature nutrition counseling and digital tools.
~$2.6B annual CapEx budget includes store refreshes; up to 20% of store space could shift to health services, with renovations funded within existing capital plans.
Latest events from CVS Health
- Separation aims to unlock standalone growth while preserving investment-grade balance sheets.CVS
8th Annual Wolfe Research Healthcare Conference - Care delivery expansion and post-deleveraging capital choices shape the forward strategy.CVS
30th Annual Credit Suisse Healthcare Conference - PBM cost controls, health plan growth and integrated care underpin the outlook.CVS
The 2016 Morgan Stanley Global Healthcare Conference - Integrated pharmacy scale supported growth and more than $5B in planned 2016 shareholder returns.CVS
The UBS 2016 Global Healthcare Conference - Integrated pharmacy and clinical programs aim to improve outcomes and reduce care costs.CVS
UBS Global Healthcare Conference 2017 - Signify bolsters in-home care and value-based strategy amid stable utilization.CVS
Morgan Stanley 20th Annual Global Healthcare Conference - Cost savings and payer partnerships support long-term growth and shareholder returns.CVS
Investor Day 2016 - A $77B Aetna deal targets integrated care and $750M in year-two synergies.CVS
M&A announcement - FY18 operating profit growth guided to 1%–4%, tempered by PBM and deal-related headwinds.CVS
Guidance